Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH agonists?

A comment to a 2009 Fertil Steril article “Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity…”

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Citation Page #: 298 (letter)
Journal: Fertil Steril
Author Publication: Oktay et al.
Publication Link: http://linkinghub.elsevier.com/retrieve/pii/S001502820801025X
Date: 2009